Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
Isha Health is a U.S.-based online ketamine-assisted psychotherapy service focused on telehealth evaluations, prescriptions, and at-home treatment guidance for depression, anxiety, and PTSD. Its materials state that it serves states including Arizona, California, Colorado, Florida, Georgia, Oregon, Texas, and Washington, and emphasize involvement from licensed physicians or psychiatric nurse practitioners. Strictly speaking, it is not a typical SaaS or enterprise software product, but rather a healthcare service platform with online booking, directory, and patient management capabilities.
The patient journey is relatively complete: a 60-minute initial video consultation, assessment of symptoms and medical history, a personalized treatment plan, prescription delivery to a compounding pharmacy, medication delivery within 3–5 business days, emailed treatment instructions, the ability to ask the care team questions during treatment, and follow-up 30-minute visits. The platform also mentions ongoing monitoring using PHQ-9 and GAD-7, with dosage and frequency adjusted based on response. On the clinician/therapist side, there is a Clinician Directory that supports filtering by state, specialty, access method, insurance, and more. Clinicians can join for free, receive an independent profile page, and use AI to import information from Psychology Today or their practice website.
For patients, Isha Health charges per visit: the initial consultation is normally $796 and currently $398; follow-up visits are $398; ketamine medication costs extra, typically $50–150 per 30 days. It does not accept insurance, Medicaid, or Medicare, but supports HSA/FSA and can provide a superbill for users to attempt reimbursement on their own. The clinician directory is free, with no subscription fees or hidden costs. Overall pricing is transparent, but the total cost should include medication fees and ongoing follow-up visits.
The strengths are a clear remote care workflow, potentially fast response times, an emphasis on personalized treatment plans, and some publicly shared outcomes data based on clinical scales. The therapist directory also helps connect patients with additional therapeutic support. The drawbacks are limited state coverage and the financial pressure of paying fully out of pocket. The materials also do not disclose key enterprise software capabilities such as HIPAA details, encryption, data retention, permission systems, or APIs. As a SaaS procurement target, it provides very limited information on organization-level collaboration, auditability, and developer ecosystem support.
It is best suited to patients located in supported U.S. states who are willing to self-pay and want remote ketamine-assisted treatment. It may also be useful for relevant therapists who want to create a free visibility profile. For users in China, the materials do not explain network accessibility or cross-border payment options. More importantly, prescription drugs, telemedicine practice, and ketamine control are all subject to strict regulation, so it is not a practical direct alternative for users in mainland China. Local, compliant psychiatric or mental health services should be prioritized instead.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on isha.health official site.
isha.health is an United States Health provider. TG4G tracks its product information, with monthly pricing from $398.00, an overall rating of 5.0/10, and a China-accessibility score of Limited (proxy recommended). Click "Visit Official Site" to reach isha.health directly.